Lansoprazole
Product Images NDC 64679-670

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 64679-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Usa Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6aa7ef29 7bb4 4c41 9059 59ebbd1de24d 01

Chemical structure of lansoprazole, showing its molecular components including a benzimidazole ring, sulfinyl linkage, and substituted pyridine ring.*

FDA Label Image

6aa7ef29 7bb4 4c41 9059 59ebbd1de24d 02

A line graph showing the mean severity of day heartburn over time (days from start of treatment) for three groups: placebo, 15 mg Lansoprazole once daily (QD), and 30 mg Lansoprazole QD. The graph indicates decreasing heartburn severity after treatment begins, with Lansoprazole groups showing greater reduction compared to placebo over approximately 60 days.*

FDA Label Image

6aa7ef29 7bb4 4c41 9059 59ebbd1de24d 03

A line graph showing mean severity of day heartburn over days from start of treatment comparing placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. Three lines correspond to placebo (open circles), Lansoprazole 15 mg once daily (solid circles), and Lansoprazole 30 mg once daily (solid triangles). Severity decreases over time for both doses of Lansoprazole compared to placebo.*

FDA Label Image

6aa7ef29 7bb4 4c41 9059 59ebbd1de24d 04

Label for Lansoprazole Delayed-release Capsules, USP 15 mg, containing 30 capsules. The label states each pink and green capsule contains 15 mg of lansoprazole as enteric-coated granules. It is labeled by Wockhardt USA LLC. Dosage instructions direct users to the accompanying prescribing information. Additional details include storage instructions, pharmacist dispensing guidance, barcode, lot, and expiration placeholders.*

FDA Label Image

6aa7ef29 7bb4 4c41 9059 59ebbd1de24d 05

Lansoprazole 30 mg Delayed-release Capsules, USP label by Wockhardt USA LLC. The image shows a capsule bottle label with dosage strength of 30 mg, containing 90 capsules. The label includes usage instructions, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.